-
-
-
-
-
-
-
German government to drop variable drug discounting plans - Reuters
-
-
-
-
-
-
-
China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck
-
-
-
-
-
-
-
Novartis reports positive two-year results for Fabhalta in kidney disease
-
-
-
-
-
-
-
Increasing unusual call option volume: NVS BRBR BNO OMC QGEN SCO CGNX WEAT ZVRA
-
-
-
-
-
-
-
Novartis licenses peptide asset from PepLib for radioligand therapy
-
-
-
-
-
-
-
Novartis selects Salesforce Agentforce for global customer engagement
-
-
-
-
-
-
-
TD Cowen on Novartis (NVS): 'Meet Management Meeting Showcases Growth Drivers And Pipeline'
-
433,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

